Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Osteoporosis
Can raloxifene be combined with stronger osteoporosis agents in patients who are on raloxifene for a breast cancer diagnosis?
Related Questions
How would you manage a patient with symptomatic Paget’s disease and osteoporosis who developed new fragility fractures while on Fosamax?
Would you use anabolic agents (romosozumab or PTH analogues) for osteoporosis treatment in patients with CKD?
Is elevated bone specific alkaline phosphatase an absolute contraindication to teriparatide?
What is your approach to management of patients with recurrent nephrolithiasis and osteoporosis who are receiving teriparatide?
What treatment options would you consider for a young patient with limited mobility, low bone mass and multiple vertebral compression fractures who is on dialysis for advanced kidney disease?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Is it safe to combine Prolia with other immunosuppressants?
How do you use P1NP in your clinical practice to guide management of osteoporosis?
Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?
How frequently do you monitor for hypocalcemia in patients on romosozumab?
